.png)
Cite this article as: Gök Sargın Z. Risk of reactivation of hepatitis B in hepatitis B surface antigen-negative and hepatitis B core antigen antibody positive patients receiving biologic therapy. Turk J Gastroenterol. 2023;34(3):308-309.
Department of Gastroenterology and Hepatology, Kırıkkale University Faculty of Medicine, Kırıkkale, Turkey
Cite this article as: Gök Sargın Z. Risk of reactivation of hepatitis B in hepatitis B surface antigen-negative and hepatitis B core antigen antibody positive patients receiving biologic therapy. Turk J Gastroenterol. 2023;34(3):308-309.